ASMB — Assembly Biosciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapNeutral

Annual balance sheet for Assembly Biosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	147	91.6	130	112	248
Net Total Accounts Receivable
Net Total Receivables	0.336	0.944	0.043	0	0.974
Prepaid Expenses
Total Current Assets	154	97	134	116	255
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	7.18	3.94	2.72	3.35	2.73
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	191	102	137	119	258
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	16.1	16.3	39.2	47.8	48.8
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	22.1	19.1	95.7	85.8	50.8
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Total Equity	169	82.7	41.1	33.4	207
Total Liabilities & Shareholders' Equity	191	102	137	119	258
Total Common Shares Outstanding
Total Preferred Shares Outstanding